Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Targeted NGS voor screening op resistente tuberculose
mrt 2025 | Bacteriële infecties, Tuberculose